Successful virological outcome in an HIV-infected individual with a three-class resistant variant and an insertion in the protease genome with a Tipranavir based regimen.
BACKGROUND
Multi-class HIV-1 resistant variants are not rare nowadays. Genotypic and phenotypic resistance testing (including virtual phenotype) constitutes an important tool for optimizing antiretroviral treatment.


OBJECTIVE
To report a case of discrepancy between resistance interpretation and virological outcome.


METHODS
A case of a multi-drug experienced patient is presented. Genotypic and/or virtual phenotypic testing analysis was used.


RESULTS
The patient after 10 years of antiretroviral therapy with 11 different regimens unable to produce full virological suppression and with a rapidly declining CD4 count, achieved a successful virological outcome with a scheme containing Tipranavir boosted with low dose of ritonavir. Of note, the patient was screened for Tipranavir 1182.48 study and was found ineligible after genotypic analysis.


CONCLUSIONS
Virologic suppression was achieved despite the fact that neither an active agent was included in the backbone regimen nor the resistance profile could ensure the effectiveness of Tipranavir.
Panagopoulos
P
P
Attikon University General Hospital, Athens, Greece. ppanag@med.uoa.gr
Paraskevis
D
D
Antoniadou
A
A
Papadopoulos
A
A
Poulakou
G
G
Hatzakis
A
A
Giamarellou
H
H
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D024921:Drug Resistance, Multiple, Viral / Q000187:drug effects / Q000235:genetics; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D008297:Male; D016254:Mutagenesis, Insertional / Q000187:drug effects* / Q000235:genetics; D010447:Peptide Hydrolases / Q000235:genetics; D010641:Phenotype; D011725:Pyridines / Q000627:therapeutic use*; D011753:Pyrones / Q000627:therapeutic use*; D013449:Sulfonamides; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; D010447:Peptide Hydrolases; C107201:tipranavir
AIDS. 2002 Jan 25;16(2):209-18
11807305
Clin Infect Dis. 2005 Jun 15;40(12):1828-36
15909273
AIDS. 2004 Nov 5;18(16):2153-61
15577648
J Infect Dis. 2003 Jul 15;188(2):194-201
12854073
J Clin Virol. 2005 Jul;33(3):224-9
15911444
AIDS. 2002 May 24;16(8):1131-8
12004271
Drugs. 2005;65(12):1669-77; discussion 1678-9
16060700